Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

We recently published a list of 10 Hottest Mega-Cap Stocks So Far in 2025. In this article, we are going to take a look at ...

Shares of Boston Scientific Corp. BSX advanced 1.30% to $96.89 Wednesday, on what proved to be an all-around great trading ...

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Marie ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to Boston Scientific (BSX – Research Report). The ...

Boston Scientific Corp (BSX) stock saw a modest uptick, ending the day at $98.17 which represents a slight increase of $1.28 or 1.32% from the prior close of $96.89. The stock opened at $97.03 and ...

Boston Scientific Corporation (BSX) shares rise on acquisitions – earnings due in early February.

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

In a recent update, RBC Capital analysts have maintained their Outperform rating on Boston Scientific (NYSE:BSX) shares, with ...

Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.

Shares of NYSE BSX opened at $96.87 on Thursday. The firm’s 50 day moving average price is $90.36 and its 200-day moving average price is $84.15. Boston Scientific Co. has a 52-week low of $59. ...